GlassScriptPhysician profile
Michelle Renee Joseph
NPI 1700414695
$592.12
in general payments reported to CMS, 2019-2025
14 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.29 · 2024: $86.22 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $104.85 | 2025 | |
| Lilly USA, LLC | $83.87 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $68.77 | 2024-2025 | Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $62.59 | 2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.81 | 2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.55 | 2024-2025 | Jardiance |
| Dexcom, INC. | $38.07 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $29.07 | 2025 | Ozempic, Rybelsus |
| Sumitomo Pharma America, INC. | $24.80 | 2025 | Gemtesa |
| Pfizer INC. | $18.71 | 2025 | |
| Novartis Pharmaceuticals Corporation | $17.16 | 2025 | |
| Exact Sciences Corporation | $16.45 | 2025 | Cologuard Collection Kit |
| Genzyme Corporation | $15.29 | 2023 | |
| Medtronic, INC. | $15.13 | 2024 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.